{
    "nctId": "NCT03333655",
    "officialTitle": "A Multicenter Study to Explore the Mechanism of Acquired Immune Escape In Patients With Metastatic Cancer Progressing on Checkpoint Inhibitor Therapy",
    "inclusionCriteria": "* Response assessment of complete response (CR), partial response (PR), or long-term stable disease (SD) for \\>6 months with a cancer immunotherapy treatment for metastatic cancer or hematologic malignancies either through a marketed CPI or through participation in a Roche/Genentech CPI clinical trial.\n* Availability of tissue sample.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Pregnant, lactating, or intending to become pregnant during the study.\n* Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial."
}